1. Home
  2. LASR vs CYRX Comparison

LASR vs CYRX Comparison

Compare LASR & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LASR
  • CYRX
  • Stock Information
  • Founded
  • LASR 2000
  • CYRX 1999
  • Country
  • LASR United States
  • CYRX United States
  • Employees
  • LASR N/A
  • CYRX N/A
  • Industry
  • LASR Semiconductors
  • CYRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LASR Technology
  • CYRX Health Care
  • Exchange
  • LASR Nasdaq
  • CYRX Nasdaq
  • Market Cap
  • LASR N/A
  • CYRX 277.5M
  • IPO Year
  • LASR 2018
  • CYRX N/A
  • Fundamental
  • Price
  • LASR $8.61
  • CYRX $7.04
  • Analyst Decision
  • LASR Strong Buy
  • CYRX Strong Buy
  • Analyst Count
  • LASR 4
  • CYRX 8
  • Target Price
  • LASR $15.13
  • CYRX $10.75
  • AVG Volume (30 Days)
  • LASR 268.3K
  • CYRX 450.9K
  • Earning Date
  • LASR 05-08-2025
  • CYRX 05-07-2025
  • Dividend Yield
  • LASR N/A
  • CYRX N/A
  • EPS Growth
  • LASR N/A
  • CYRX N/A
  • EPS
  • LASR N/A
  • CYRX N/A
  • Revenue
  • LASR $198,548,000.00
  • CYRX $232,134,000.00
  • Revenue This Year
  • LASR $8.26
  • CYRX N/A
  • Revenue Next Year
  • LASR $10.40
  • CYRX $8.19
  • P/E Ratio
  • LASR N/A
  • CYRX N/A
  • Revenue Growth
  • LASR N/A
  • CYRX 3.16
  • 52 Week Low
  • LASR $6.20
  • CYRX $4.58
  • 52 Week High
  • LASR $14.73
  • CYRX $16.89
  • Technical
  • Relative Strength Index (RSI)
  • LASR 60.32
  • CYRX 65.12
  • Support Level
  • LASR $7.88
  • CYRX $5.43
  • Resistance Level
  • LASR $8.60
  • CYRX $6.00
  • Average True Range (ATR)
  • LASR 0.33
  • CYRX 0.44
  • MACD
  • LASR 0.16
  • CYRX 0.10
  • Stochastic Oscillator
  • LASR 97.38
  • CYRX 96.71

About CYRX CryoPort Inc.

CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

Share on Social Networks: